Cathay Biotech (SH:688065) Xin Lang Cai Jing·2025-10-09 07:47Core Viewpoint - Shanghai Kasei Biotechnology Co., Ltd. has announced a share repurchase plan proposed by its original controlling shareholder, with a total repurchase amount expected to be between 10 million and 20 million yuan [1] Group 1: Share Repurchase Details - The share repurchase plan was approved by the board of directors on October 21, 2024, and will be implemented from October 21, 2024, to October 20, 2025 [1] - As of September 30, 2025, the company has repurchased a total of 230,366 shares, accounting for 0.0319% of the total share capital [1] - The total amount spent on repurchases so far is 10,497,716.71 yuan, with the actual repurchase price ranging from 44.08 yuan to 53.40 yuan per share [1] Group 2: Future Plans - The company will continue to advance the share repurchase as per regulations and will disclose information in a timely manner [1]